Protecting Two Hearts: Understanding Opiate Withdrawal in Pregnancy

April 25, 2026
2:58 am

Protecting Two Hearts: Understanding Opiate Withdrawal in Pregnancy

When Two Lives Depend on the Right Care: Opiate Withdrawal in Pregnancy

Opiate withdrawal in pregnancy is a serious medical situation that affects both mother and baby — and how it’s managed makes all the difference.

Here’s what you need to know right away:

Quitting opioids suddenly (“cold turkey”) during pregnancy is dangerous. It can trigger preterm labor, fetal distress, or even fetal demise.
The recommended treatment is not withdrawal — it’s medication-assisted treatment (MAT) with methadone or buprenorphine, combined with prenatal care and behavioral support.
Neonatal Abstinence Syndrome (NAS) — withdrawal symptoms in newborns — is expected but manageable with proper medical care.
Breastfeeding is encouraged for stable mothers on MAT, as it actually reduces NAS severity.
Help is available in Florida, including here in Miami, through specialized programs designed for pregnant women.

Opioid use during pregnancy has grown dramatically over the past two decades. According to national data, NAS cases rose from 1.5 per 1,000 hospital births in 1999 to 6.0 per 1,000 in 2013. By 2018, a baby was born experiencing opioid withdrawal every 15 minutes in the United States.

If you’re pregnant and struggling with opioid dependence right now, you are not alone — and you are not out of options.

The fear of withdrawal, the fear of judgment, and the fear of what this means for your baby can feel crushing. But the science is clear: staying in treatment is safer for your baby than stopping opioids abruptly. This guide walks you through everything — the risks, the treatments, what happens with your newborn, and how to get the right support.

Opiate withdrawal in pregnancy vocab explained:

Understanding Opiate Withdrawal in Pregnancy and Its Risks

When we talk about opiate withdrawal in pregnancy, we aren’t just talking about a mother feeling “sick.” We are talking about a physiological chain reaction that impacts the placenta and the developing fetus. Opioids cross the placenta easily. When a mother’s blood levels of opioids drop sharply—whether due to a missed dose, a lack of supply, or an attempt to quit “cold turkey”—the baby experiences that same drop.

This sudden “crash” is incredibly stressful for a tiny, developing body. Untreated withdrawal in a pregnant woman can lead to severe complications, including:

Preterm Labor: The stress of withdrawal can trigger uterine contractions, leading to early birth.
Fetal Distress: Fluctuations in maternal oxygen levels and heart rate during withdrawal can cause the baby’s heart rate to drop or become erratic.
Placental Abruption: In extreme cases of physiological stress, the placenta can detach from the womb, which is a life-threatening emergency for both.
Fetal Demise: Sadly, the most severe consequence of unmanaged withdrawal is miscarriage or stillbirth.

Beyond the immediate physical dangers, there are long-term concerns regarding what happens to babies exposed to heroin in the womb. While many babies go on to lead healthy lives, untreated use increases the risk of fetal growth restriction and low birth weight.

The risk of maternal relapse is another massive factor. Statistics show that when pregnant women try to detox without long-term medication support, the relapse rate is staggering—between 59% and 90%. In Florida, the stakes are high; data shows that 22.8% of women enrolled in Medicaid filled at least one opioid prescription during pregnancy in 2007. Whether the use began with a prescription or illicit substances, the biological reality of dependence remains the same.

Screening and Identifying Opioid Use Disorder (OUD)

Because the stakes are so high, medical organizations like ACOG (American College of Obstetricians and Gynecologists) recommend universal screening for all pregnant patients. This isn’t about “catching” anyone or being punitive; it’s about ensuring the safest possible birth.

Doctors often use validated tools to start the conversation, such as:

The 4P’s: Asking about drug use in Parents, Partners, Past, and Pregnancy.
CRAFFT: A screening tool specifically designed for adolescents and young adults.
NIDA Quick Screen: A rapid series of questions to gauge the level of substance use.

The SBIRT model (Screening, Brief Intervention, and Referral to Treatment) is the gold standard for care. It allows providers to identify the issue, offer immediate support, and refer the patient to specialized detox for pregnant women or long-term maintenance programs.

In a Miami urban teaching hospital, urine screening detected opioids in 2.6% of pregnant women. It is important to note that urine toxicology can sometimes produce false positives due to common medications (like certain decongestants or antidepressants). This is why we always advocate for a non-judgmental, conversation-first approach.

Clinical Signs of Opiate Withdrawal in Pregnancy

If a woman is currently experiencing withdrawal, clinicians use the COWS (Clinical Opiate Withdrawal Scale) to measure the severity. It’s important to distinguish withdrawal from common pregnancy discomforts like morning sickness or back pain. Signs of withdrawal include:

Autonomic Hyperactivity: Sweating, racing heart, and dilated pupils.
GI Distress: Intense nausea, vomiting, and diarrhea.
Psychological Symptoms: Severe anxiety, irritability, and intense maternal cravings.
Physical Markers: Yawning, “goosebumps” (piloerection), and muscle aches.

The Standard of Care: Medication-Assisted Treatment (MAT)

The medical community is unanimous: Medication-Assisted Treatment (MAT) is the standard of care for OUD during pregnancy. This typically involves using either Methadone or Buprenorphine. These medications stabilize the mother’s brain chemistry, prevent withdrawal, and provide a steady environment for the fetus.

Methadone vs. Buprenorphine

Both medications are effective, but they have different profiles. The MOTHER trial, a landmark study, provided some incredible insights into how these drugs compare:

Feature	Methadone	Buprenorphine
NAS Severity	Can be more intense	Generally less severe
Morphine Needs	Standard dose	89% less morphine needed for baby
Hospital Stay	Average 17.5 days	43% shorter stay (approx. 10 days)
Dosing	Daily at a clinic	Can be office-based/at home

Buprenorphine-exposed neonates often require 58% shorter duration of medical treatment for NAS compared to those exposed to methadone. However, methadone has a longer track record and might be better for women who struggle with high-intensity cravings or have a long history of heavy use. You can read more about methadone and pregnancy guidelines to see which might be right for your situation.

Because of the way a woman’s body changes during pregnancy—specifically how the liver and kidneys process medicine faster—doctors often utilize split dosing. Instead of one large dose, the medication is split into two or three smaller doses throughout the day to keep levels stable and prevent “mini-withdrawals” between doses.

Why Medically Supervised Opiate Withdrawal in Pregnancy is Discouraged

We often hear from moms who say, “I just want to be clean before the baby comes.” While that’s a beautiful goal, medically supervised opiate withdrawal in pregnancy (detoxification) is generally discouraged by ACOG and SAMHSA.

Why? Because the recidivism (relapse) rate is between 59% and 90%. When a person relapses after a period of abstinence, their tolerance is lower, making the risk of a fatal overdose much higher. Furthermore, the cycle of withdrawal and relapse is far more stressful for the fetus than the steady, controlled presence of a maintenance medication. Stabilization, not detoxification, is the priority for a healthy delivery.

Managing Neonatal Abstinence Syndrome (NAS/NOWS)

If you are on MAT or using opioids, your baby will likely experience some form of Neonatal Abstinence Syndrome (NAS), also called Neonatal Opioid Withdrawal Syndrome (NOWS). While the word “withdrawal” sounds scary, it is a temporary and treatable condition.

In the past, doctors relied heavily on the Finnegan Scoring System, which often led to babies being given morphine or methadone at the first sign of a tremor. Today, many hospitals (including those in the Miami area) are moving toward the Eat, Sleep, Console (ESC) model.

ESC focuses on the baby’s function:

Can the baby Eat a sufficient amount?
Can the baby Sleep for at least an hour?
Can the baby be Consoled within 10 minutes?

If the answer is yes, we continue with non-pharmacological care. This includes:

Rooming-in: Keeping the baby in the same room as the mother rather than the NICU.
Low-Stimulation Environment: Dim lights and quiet rooms to help the baby’s sensitive nervous system.
Skin-to-Skin Contact: This regulates the baby’s heart rate and temperature.

For more details on what this looks like, see our guide on understanding NAS and infant withdrawal. One of the most powerful “medicines” for NAS is actually breastfeeding. Breast milk contains tiny, safe amounts of the mother’s MAT medication, which helps wean the baby naturally and significantly reduces the severity of withdrawal symptoms.

Peripartum Care and Long-Term Outlook

When it comes time for delivery, pain management is a top priority. Being on MAT does not mean you have to suffer through labor without help.

Intrapartum Pain: Women on MAT often have a higher tolerance for pain and may require higher doses of standard pain relief. Epidural anesthesia is highly recommended and perfectly safe.
Avoid Agonist-Antagonists: Medications like Butorphanol (Stadol) or Nalbuphine (Nubain) should be avoided, as they can trigger immediate, intense withdrawal in someone on methadone or buprenorphine.
Postpartum Depression: Up to 45% of women with OUD experience postpartum depression. It is vital to have mental health support lined up before you leave the hospital.

Long-term studies on children exposed to opioids in utero are generally encouraging. While some studies suggest a slight risk of behavioral issues or developmental delays, these are often heavily influenced by environmental factors like poverty, nutrition, and home stability. With a supportive environment, these children typically meet their milestones just like their peers.

Before discharge, we emphasize the importance of a solid plan. This includes outpatient referrals in Miami for continued MAT, contraception counseling (to prevent unintended pregnancies while in early recovery), and a “safety plan” for the home.

Frequently Asked Questions

Is it safe to quit opioids “cold turkey” while pregnant?

No. Abruptly stopping opioids can cause the uterus to contract and the placenta to function poorly. This leads to fetal distress and, in some cases, preterm labor or fetal loss. Always seek medical supervision to transition to a safe maintenance medication.

Can I breastfeed while on methadone or buprenorphine?

Yes! ACOG and the Academy of Breastfeeding Medicine encourage breastfeeding for stable mothers on MAT, provided they do not have other contraindications like HIV. It promotes bonding and is one of the most effective ways to treat NAS symptoms in the baby.

How long does a baby stay in the hospital for NAS?

Most hospitals require a 5-to-7-day observation period for infants exposed to opioids to ensure withdrawal symptoms are managed. However, using the ESC model and breastfeeding can result in a 43% shorter hospital stay compared to traditional methods.

Conclusion

Navigating opiate withdrawal in pregnancy is a journey that requires courage, honesty, and the right medical partners. At Summer House Detox Center, we understand that you are fighting for two hearts—yours and your baby’s.

Our Miami-based facility provides a foundation of dignity and support. While the standard of care for pregnancy is long-term maintenance, we are here to provide the medical supervision, stabilization, and referrals necessary to ensure you and your baby have the best start possible. Recovery is not just about stopping a substance; it’s about building a life where you don’t need it anymore.

If you’re in Florida and need a safe place to start your journey, we are here to help. Explore our Medically Supervised Opiate Detox Services or call us today to speak with someone who understands exactly what you’re going through. You don’t have to do this alone.